Profit

Abbott sees India as 'key pillar' for growth

PUBLISHED ON: August 18, 2011 | Duration: 2 min, 44 sec

facebooktwitteremailkoo
loading..
Pharma giant Abbott is charting out big growth plans in the $20-billion Indian pharma market. The firm says India is a top priority in the emerging markets, a segment which contributes over a quarter to Abbott's global sales.
ALSO WATCH
Moderna Approved For Emergency Use, 4th Vaccine Okayed By India

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com